ALBUQUERQUE, N.M. & LEXINGTON, Mass.--(BUSINESS WIRE)-- Lumidigm and Imprivata today announced a partnership to deliver an integrated solution for healthcare clinicians that require reliable and fast access to electronic medical record (EMR) applications when wearing surgical gloves. With Lumidigm’s award-winning biometric sensors integrated into the Imprivata OneSign® enterprise single sign-on (ESSO) and authentication platform, healthcare providers obtain fast and streamlined access to EMR applications with a simple touch of a finger — even when gloved.
Biometrics access has been proven to be the most simple and cost-effective way to maintain patient privacy and to manage the distribution of controlled substances as mandated by DEA regulations. Users that are biometrically enrolled in Imprivata’s OneSign platform will benefit from its central management and reporting capabilities which support secure access to pharmaceuticals, medical equipment and patient data.
“Lumidigm’s biometric sensors and OneSign give clinicians fast access to EMR applications regardless of environmental conditions,” said Ed Gaudet, chief marketing officer at Imprivata. “With support for Lumidigm devices, our customers can leverage their existing OneSign investments across clinician workflows that involve surgical gloves.”
“Using Imprivata’s OneSign solution in tandem with the security and superior performance of Lumidigm biometric sensors is essential in healthcare applications where security is a must but where security cannot interfere with critical-care technicians, doctors or nurses attending to their jobs,” explains Phil Scarfo, Lumidigm senior vice president of sales and marketing. “Enterprise single sign-on and biometric authentication eliminate clinician frustrations with multiple passwords, two-tier authentication and lost tokens. Imprivata OneSign consolidates multiple applications into a single access point and completes a healthcare provider’s investment by merging all authentication needs to a single finger.”
Lumidigm’s partnership with Imprivata allows doctors, nurses, staff and other employees to access multiple applications throughout a hospital with a single biometric enrollment. Lumidigm multispectral imaging sensors capture fingerprint data beneath the surface of the skin so that dryness or even damaged or worn fingers create no problems for reliable reads. Using multiple wavelengths of light and advanced polarization techniques to extract unique fingerprint characteristics from both the surface and subsurface of the skin, Lumidigm’s sensors provide results that are more consistent, more inclusive and more tamper resistant than conventional biometric readers.
The Lumidigm fingerprint solution is being featured today through Wednesday in Booth #5242 at the HIMSS11 Exhibition at the Orange County Convention Center in Orlando, Fla. The Imprivata OneSign solution is being featured in Booth #3872.
The research firm of Frost & Sullivan recently awarded the New Product Innovation of the Year Award, Fingerprint Biometrics, North America, 2010, to Lumidigm. According to Frost & Sullivan, Lumidigm’s “innovative technology allows Lumidigm fingerprint sensors to provide highly accurate biometric data even in adverse conditions where traditional fingerprint sensors fail.”
More information on Lumidigm biometric solutions is available at www.lumidigm.com.
With more than one million health care users, Imprivata is the #1 independent provider of single sign-on and access management solutions for health care, government, finance and other regulated industries. By strengthening user authentication, streamlining application access and simplifying compliance reporting across multiple computing environments, customers realize improved workflows, increased security and compliance with government regulations.
Imprivata has received numerous product awards and top review ratings from leading industry publications and analysts, including a Strong Positive rating in Gartner’s 2010 ESSO Marketscope, the #1 ranking in the KLAS SSO Performance report and the #1 rating in 2010 Best in KLAS and Category Leaders report. Headquartered in Lexington, Mass., Imprivata partners with over 200 resellers, and serves the access security needs of more than 1,100 customers around the world. For more information, please visit www.imprivata.com or follow us on Twitter at @Imprivata.
Lumidigm Inc., the multispectral imaging biometrics company, is dedicated to enabling convenient, secure, and reliable identification and verification. Lumidigm fingerprint sensors capture superior images quickly, on all people, in all conditions. Everyone can be enrolled. Everyone can be verified. Lumidigm’s sensors are quick and easy to use — perfect for any application in which speed, security and reliability are paramount. Headquartered in Albuquerque, New Mexico, Lumidigm sensors are distributed worldwide. Lumidigm’s initial venture capital investors are DFJ New England, Draper Fisher Jurvetson, Epic Ventures, Intel Capital, International Venture Fund and Solstice Capital. Other investors include Methode Electronics, Motorola Ventures, New Mexico Co-Investment Partners managed by Fort Washington Capital, and Sun Mountain Capital. For more information, visit www.lumidigm.com.
NOTE TO EDITORS: High-resolution photographs of Lumidigm’s Venus and Mercury fingerprint sensors are available at www.brighamscully.com. Click Photo Downloads/Lumidigm.
RSS Feed to Imprivata News: http://feeds.feedburner.com/ImprivataNews
Follow Imprivata on Twitter: https://twitter.com/Imprivata
KEYWORDS: United States North America Massachusetts New Mexico
INDUSTRY KEYWORDS: Technology Data Management Hardware Networks Software Security Health Hospitals Other Health General Health